JP2013506003A5 - - Google Patents

Download PDF

Info

Publication number
JP2013506003A5
JP2013506003A5 JP2012532230A JP2012532230A JP2013506003A5 JP 2013506003 A5 JP2013506003 A5 JP 2013506003A5 JP 2012532230 A JP2012532230 A JP 2012532230A JP 2012532230 A JP2012532230 A JP 2012532230A JP 2013506003 A5 JP2013506003 A5 JP 2013506003A5
Authority
JP
Japan
Prior art keywords
alkyl
group
isopropyl
methoxy
pyrazolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012532230A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013506003A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/050486 external-priority patent/WO2011041287A1/en
Publication of JP2013506003A publication Critical patent/JP2013506003A/ja
Publication of JP2013506003A5 publication Critical patent/JP2013506003A5/ja
Pending legal-status Critical Current

Links

JP2012532230A 2009-09-29 2010-09-28 スフィンゴシン−1−リン酸−2(s1p2)受容体のサブタイプ選択的調節因子としての縮合環ピリジン化合物 Pending JP2013506003A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24664209P 2009-09-29 2009-09-29
US61/246,642 2009-09-29
PCT/US2010/050486 WO2011041287A1 (en) 2009-09-29 2010-09-28 Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (s1p2) receptors

Publications (2)

Publication Number Publication Date
JP2013506003A JP2013506003A (ja) 2013-02-21
JP2013506003A5 true JP2013506003A5 (enExample) 2013-11-14

Family

ID=43031503

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012532230A Pending JP2013506003A (ja) 2009-09-29 2010-09-28 スフィンゴシン−1−リン酸−2(s1p2)受容体のサブタイプ選択的調節因子としての縮合環ピリジン化合物

Country Status (15)

Country Link
US (2) US8507682B2 (enExample)
EP (1) EP2483245A1 (enExample)
JP (1) JP2013506003A (enExample)
KR (1) KR20120087932A (enExample)
CN (1) CN102741232A (enExample)
AU (1) AU2010300791A1 (enExample)
BR (1) BR112012007095A2 (enExample)
CA (1) CA2775587A1 (enExample)
IL (1) IL218843A0 (enExample)
MX (1) MX2012003718A (enExample)
NZ (1) NZ599595A (enExample)
RU (1) RU2012114718A (enExample)
SG (1) SG10201406178WA (enExample)
WO (1) WO2011041287A1 (enExample)
ZA (1) ZA201202366B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104334556B (zh) 2012-03-26 2017-05-17 爱若优生物科技有限公司 新型1‑磷酸鞘氨醇受体拮抗剂
WO2014158302A1 (en) * 2013-03-25 2014-10-02 Swenson Rolf Eric Novel sphingosine 1-phosphate receptor antagonists
JP6867165B2 (ja) * 2014-06-02 2021-04-28 ダルハウジー ユニバーシティー S1pr2の阻害による家族性滲出性硝子体網膜症の処置
HK1246288A1 (zh) * 2015-06-01 2018-09-07 Dalhousie University S1pr2拮抗剂及其用途
US10858358B2 (en) 2015-06-01 2020-12-08 Dalhousie University S1PR2 antagonists and uses therefor
US10487082B2 (en) 2015-06-01 2019-11-26 Dalhousie University S1PR2 antagonists and uses therefor
CN107382965A (zh) * 2017-08-14 2017-11-24 河南科技大学第附属医院 具有抗肿瘤活性的新型s1p‑1受体激动剂药物分子的合成方法
CN113896646B (zh) * 2020-07-06 2023-06-02 浙江海森药业股份有限公司 一种4-甲基-3-氧代-n-苯基戊酰胺的高效绿色制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146810A3 (de) 1983-12-05 1987-05-13 Solco Basel AG Verfahren zur Herstellung von Sphingosinderivaten
US5110987A (en) 1988-06-17 1992-05-05 Emory University Method of preparing sphingosine derivatives
ZA902794B (en) 1989-04-18 1991-04-24 Duphar Int Res New 3-n substituted carbamoyl-indole derivatives
US5294722A (en) 1992-04-16 1994-03-15 E. R. Squibb & Sons, Inc. Process for the preparation of imidazoles useful in angiotensin II antagonism
US5403851A (en) 1994-04-05 1995-04-04 Interneuron Pharmaceuticals, Inc. Substituted tryptamines, phenalkylamines and related compounds
US6235912B1 (en) 1997-03-12 2001-05-22 Takara Shuzo Co., Ltd. Sphingosine analogues
JP4091250B2 (ja) 1997-09-11 2008-05-28 タカラバイオ株式会社 スフィンゴシン類誘導体及び医薬組成物
AU2001264313A1 (en) * 2000-06-20 2002-01-02 Japan Tobacco Inc. Pyrazolopyridine compounds and use thereof as drugs
US20020183762A1 (en) 2001-06-01 2002-12-05 Ams Research Corporation Bone anchor inserters and methods
DE60221391T2 (de) 2001-06-20 2008-04-17 Wyeth Substituierte indolsäurederivate als inhibitoren von plasminogen-aktivator-inhibitor-1 (pai-1)
US20040235794A1 (en) * 2001-09-04 2004-11-25 Shinji Nakade Remedies for respiratory diseases comprising sphingosine-1-phosphate receptor controller
WO2003051876A1 (en) * 2001-12-14 2003-06-26 Japan Tobacco Inc. Pyrazolopyridine derivatives and medicinal use thereof
GB0206876D0 (en) * 2002-03-22 2002-05-01 Merck Sharp & Dohme Therapeutic agents
KR20050004214A (ko) 2002-05-31 2005-01-12 에자이 가부시키가이샤 피라졸 화합물 및 이것을 포함하여 이루어지는 의약 조성물
WO2008154470A1 (en) 2007-06-08 2008-12-18 University Of Connecticut Nhibitor of the receptor activity of the s1p2 receptor for inhibiting pathological angiogenesis in the eye
WO2009074969A2 (en) * 2007-12-12 2009-06-18 University Of Lausanne Sphingosine-1-phosphate, analogs and antagonists for use as medicaments

Similar Documents

Publication Publication Date Title
JP2013510122A5 (enExample)
RU2015126015A (ru) Новые улавливатели в лечении макулодистрофии
RU2014113679A (ru) N-(2-амино-6,6-дифтор-4,4а,5,6,7,7а-гексагидро-циклопента[e][1,3]оксазин-4-ил)-фенил)-амиды в качестве ингибиторов бета-секретазы 1
JP2016505637A5 (enExample)
RU2012114718A (ru) Пиридиновые соединения конденсированного кольца как подтип-селективные модуляторы рецепторов сфингозин-1-фосфата-2 (s1p2)
JP2013543896A5 (enExample)
JP2013519684A5 (enExample)
JP2013537203A5 (enExample)
JP2014502979A5 (enExample)
JP2007505877A5 (enExample)
JP2014505107A5 (enExample)
JP2017517538A5 (enExample)
JP2013533253A5 (enExample)
JP2008523126A5 (enExample)
RU2010101302A (ru) Замещенные оксазолидиноны и их применение
JP2010522710A5 (enExample)
JP2015508092A5 (enExample)
RU2009123525A (ru) ПРОИЗВОДНЫЕ 5-СУЛЬФАНИЛМЕТИЛ[1,2,4}ТРИАЗОЛ[1,5-а]ПИРИМИДИН-7-ОЛА В КАЧЕСТВЕ АНТАГОНИСТОВ CXCR2
JP2015521156A5 (enExample)
JP2017526724A5 (enExample)
JP2011524896A5 (enExample)
JP2020521772A5 (enExample)
JP2013517300A5 (enExample)
JP2013544811A5 (enExample)
JP2013508384A5 (enExample)